J Korean Neurol Assoc.
2004 Aug;22(4):399-401.
A Case of Successful Treatment During Migraine Aura Using Isometheptene Compound
- Affiliations
-
- 1Department of Neurology, Yong-In Mental Hospital, Yongin, Korea. taihwan@medigate.net
- 2Department of Neurology, Chung-Ang University College of Medicine, Seoul, Korea.
Abstract
- Taking medication early on for aborting migraines has proved to be more effective, but trials using triptans during the aura phase have not shown significant effectiveness. Isometheptene compounds are popularly used as an anti-migraine OTC drug. We report a 27-year-old male patient with migraine with aura whose headache attacks were consistently inhibited by an isometheptene compound administered at the early aura phase, while he received no benefits from adequate treatment during the headache phase.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Characteristics of Migraine with Aura in Korean: a Clinic Based Study
- A study on the therapeutic effects of Topiramate according to the types of migraine
- Persistent Aura Without Infarction
- Typical Aura without Headache Presenting Intermittent Transient Visual Symptom
- A Case of Stroke Associated with Isometheptene
